These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1151402)

  • 1. Studies in man of phenytoin absorption and its implications.
    Gibberd FB; Webley M
    J Neurol Neurosurg Psychiatry; 1975 Mar; 38(3):219-24. PubMed ID: 1151402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin tolerance tests.
    Handley AJ
    Br Med J; 1970 Jul; 3(5716):203-4. PubMed ID: 5448782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status epilepticus in pregnancy: effect of phenytoin malabsorption on seizure control.
    Ramsay RE; Strauss RG; Wilder BJ; Willmore LJ
    Neurology; 1978 Jan; 28(1):85-9. PubMed ID: 563542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dose on phenytoin absorption.
    Jung D; Powell JR; Walson P; Perrier D
    Clin Pharmacol Ther; 1980 Oct; 28(4):479-85. PubMed ID: 7408408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphenylhydantoin.
    Glazko AJ
    Pharmacology; 1972; 8(1):163-77. PubMed ID: 4630160
    [No Abstract]   [Full Text] [Related]  

  • 6. Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: consequences for phenytoin therapy.
    Sawchuk RJ; Rector TS
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):543-55. PubMed ID: 529023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous valproate: effects on plasma and saliva phenytoin levels.
    Pisani FD; Di Perri RG
    Neurology; 1981 Apr; 31(4):467-70. PubMed ID: 6783979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption characteristics of three phenytoin sodium products after administration of oral loading doses.
    Goff DA; Spunt AL; Jung D; Bellur SN; Fischer JH
    Clin Pharm; 1984; 3(6):634-8. PubMed ID: 6509876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo absorption of phenytoin from rat small intestine and its inhibition by phlorizin.
    Johansson O; Lindberg T; Melander A
    Acta Pharmacol Toxicol (Copenh); 1979 Oct; 45(4):265-71. PubMed ID: 525357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences on the absorption of diphenylhydantoin preparations.
    Windorfer A; Stünkel S; Weimann HM
    Neuropadiatrie; 1978 May; 9(2):120-6. PubMed ID: 581216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced gastrointestinal excretion of phenytoin in a patient with Crohn's disease.
    Lesser RP; Irace P; Kutt H; Pippenger CE; Winkelman EL; Terrentine S; Gardner M
    Epilepsia; 1984 Jun; 25(3):302-7. PubMed ID: 6723591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of food on the absorption of phenytoin in man.
    Melander A; Brante G; Johansson O; Lindberg T; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1979 May; 15(4):269-74. PubMed ID: 477711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.
    Kim YC; Kang HE; Lee MG
    Biopharm Drug Dispos; 2008 Jan; 29(1):51-61. PubMed ID: 18022993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diazepam on the biliary excretion of diphenylhydantoin in the rat.
    El-Hawari AM; Plaa GL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):14-25. PubMed ID: 850136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption and metabolism of phenytoin from tablets and capsules.
    Smith TC; Kinkel A
    Clin Pharmacol Ther; 1976 Dec; 20(6):738-42. PubMed ID: 791565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of diphenylhydantoin metabolism.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1970; 7():7-13. PubMed ID: 5514827
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
    Frey HH; Löscher W
    Am J Vet Res; 1980 Oct; 41(10):1635-8. PubMed ID: 6784613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin absorption in patients with ileojejunal bypass.
    Kennedy MC; Wade DN
    Br J Clin Pharmacol; 1979 May; 7(5):515-8. PubMed ID: 475946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.